Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$3.01 - $4.01 $84,987 - $113,222
-28,235 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$3.99 - $17.73 $7,860 - $34,928
1,970 Added 7.5%
28,235 $128,000
Q3 2020

Nov 12, 2020

SELL
$11.19 - $16.92 $29,541 - $44,668
-2,640 Reduced 9.13%
26,265 $444,000
Q2 2020

Aug 13, 2020

BUY
$4.42 - $12.66 $127,760 - $365,937
28,905 New
28,905 $324,000

Others Institutions Holding BCLI

About BRAINSTORM CELL THERAPEUTICS INC.


  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $44.5M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.